Carlyle capped a record 2025 with record fee-related earnings of $1.24 billion (up 12%) at a record 47% margin, record AUM of $477 billion, and $54 billion of inflows that far exceeded the original $40 billion target. Deployment was a record $54 billion and realized proceeds reached $34 billion, its second-best year, capped by the Medline IPO, the largest sponsor-backed IPO of all time, which helped make Carlyle the number one PE sponsor globally by IPO proceeds. Carlyle AlpInvest and Global Credit each posted record FRE and grew inflows more than 60%, and the firm returned a record $1.2 billion to shareholders. The fourth quarter itself was more muted, with fee revenues up just 2% and FRE of $290 million, and recent market volatility introduced some caution. Management repeatedly deferred forward-looking detail to its February 26th shareholder update, where it will unveil multi-year financial targets.
Thank you, Michelle. Good morning and welcome to Carlyle's fourth quarter and full year 2025 earnings call. With me on the call this morning is our Chief Executive Officer, Harvey Schwartz, and our Chief Financial Officer, Justin Plouffe. Earlier this morning, we issued a press release and a detailed earnings presentation, which is available on our Investor Relations website. This call is being webcast and a replay will be available. We will refer to certain non-GAAP financial measures during today's call. These measures should not be considered in isolation from or as a substitute for measures prepared in accordance with generally accepted accounting principles. We have provided reconciliation of these measures to GAAP in our earnings release to the extent reasonably available. Any forward-looking statements made today do not guarantee future performance, and undue reliance should not be placed on them.
These statements are based on current management expectations and involve inherent risks and uncertainties, including those identified in the risk factor section of our annual report on Form 10-K that could cause actual results to differ materially from those indicated. Carlyle assumes no obligation to update any forward-looking statements at any time. In order to ensure participation by everyone on the call today, please limit yourself to one question and return to the queue for any additional follow-ups. With that, let me turn the call over to our Chief Executive Officer, Harvey Schwartz.
Thanks, Dan. Good morning, everyone, and thank you for joining us. 2025 was a record year for Carlyle. We significantly outperformed the targets we identified at the beginning of the year. We delivered record fee-related earnings, up 12% year-over-year, materially exceeding our original forecast. We also had record FRE margins, 47%. We generated $54 billion of inflows, again significantly outperforming our original $40 billion target. Engagement across the global franchise and all client segments, from institutional to wealth, continued to build throughout the year. Transaction fees were a record $225 million, up almost 40% year-over-year. We closed out the year with record assets under management of $477 billion, driven by strong investment performance and robust fundraising across the platform. Importantly, our 2025 results demonstrate the breadth, the depth, and the durability of our global business.
Before I walk through our results in more detail, let me just briefly comment on the macro environment. Looking back at 2025, despite concerns around shifting geopolitical dynamics, the market proved to be resilient. M&A and IPO activity accelerated as market sentiment improved. 2025 ended with credit spreads near all-time tights and equity markets at all-time highs. Over the last several years, a lot has been written about low levels of monetizations in the private equity industry. Carlyle has proven to be an exception to that narrative. Since 2024, we have been the number 1 private equity sponsor globally by IPO proceeds, generating roughly $10 billion of IPO issuance over the past two years. This number is more than any other firm in our industry: $10 billion. The most recent example of this is Medline.
The IPO raised more than $7 billion and an equity valuation of $49 billion, a milestone transaction for Carlyle and the broader market. This was the largest sponsor-backed IPO of all time, the largest healthcare IPO ever, and the largest IPO of 2025. The transaction was meaningfully oversubscribed, and today is trading more than 50% above its IPO price. Medline is a great example of the types of businesses our teams look to invest in: a market leader in their sector with a great management team. Medline has an exceptional track record with more than 50 years of consecutive sales growth since inception, and Carlyle is quite proud to have partnered with Medline's founders and leadership team over the last four years. But it's not just Medline. StandardAero marked the second largest sponsor-backed U.S. IPO in 2024 and has appreciated approximately 30% since its public offering.
We listed two companies in Japan, Orion Breweries and Rigaku. Rigaku was the largest ever sponsor-backed IPO in Japan, and we IPOed Hexaware, which was the largest ever sponsor-backed IPO in India and the largest technology services IPO globally in more than a decade. While it's clearly worth noting that we've been industry-leading IPOs over the past two years, what's equally important is the breadth and diversity of these offerings across geographies and sectors. More broadly, across our GP portfolio, activity remained quite strong. We returned $18 billion of capital to investors in 2025 and $18 billion in 2024. Our teams remain highly focused on returning capital to our investors, and we expect exits momentum to continue into 2026. All of this has contributed to our strong performance across our corporate private equity funds. Our latest vintage U.S. buyout fund appreciated 17% for the year.
Our third and fourth vintage Japan buyout funds appreciated 60% and 30%, respectively, and our most recent European technology fund was up 20%. Moving on to Carlyle AlpInvest, 2025 was a record year of growth, reinforcing AlpInvest's position as one of the most influential private market solutions platforms globally. AlpInvest returned over $10 billion to our investors and invested a record $14 billion, highlighting both the breadth of the market opportunity and the scale at which the platform is operating. We closed our largest ever secondary strategy at $20 billion, continuing to grow our co-investment platform and expanded our portfolio finance strategies. Demand for secondary solutions remains strong as investors seek liquidity and portfolio optimization, and Carlyle AlpInvest continues to be a meaningful contributor to FRE growth and platform differentiation. In Global Credit and insurance, we continue to see strong momentum across the platform.
Direct lending had a record quarter of originations. We continue to grow and invest in the platform, adding key leaders and talent. We've added a new head of direct lending and senior origination professionals, enhancing origination and integration across our private credit strategies. Our performance continues to be strong, with realized losses across the portfolio running at an average of just 10 basis points per year over the past decade. Additionally, we continue our leadership position in CLOs. Amidst a record level of industry-wide issuance, Carlyle priced a record 39 CLOs last year. Carlyle was the most active CLO manager for U.S. activity, and CLO inflows of $7 billion in 2025 were up almost 20% from the prior year. I also want to touch on the momentum we have in Global Wealth. In 2025, we continue to see significant progress in our strategic approach to Global Wealth.
We had another year of record inflows, almost doubling Evergreen Wealth AUM year-over-year. Demand was strong across our Evergreen suite. We soft-launched CPEP, our private equity solution for individual investors, in the U.S. with a select group of leading RIAs. With the launch of CPEP, we've established our three key solutions across each of our businesses, with options to access Carlyle for credit, secondaries, and now PE. This is all the result of the strategic investment that we started to make three years ago. We continue to invest in resources across the entire wealth spectrum, including mass affluent, retail, and retirement. We expanded our wealth organization meaningfully this year, growing headcount by approximately 50%, and added specialized capabilities to support sustained growth across channels.
We hired a head of retirement solutions, a new role at Carlyle, reinforcing our conviction that wealth and retirement are long-term growth engines for the firm. In conclusion, we entered 2026 with strong momentum. In 2025, we delivered on our strategy in a very concrete way, growing fee-related earnings, significantly exceeding our inflows target, deploying a record amount of capital, turning money to investors, and positioning our portfolios to take advantage of a more functional exit environment. We will continue to build on the strategy and foundation we've established over the last several years. Our focus remains on investment performance, disciplined capital allocation, and delivering long-term value for our global investors and shareholders. We also announced that we are hosting a shareholder update at the end of February. Look forward to seeing you there.
At the event, we will share multi-year financial targets, more insights into the strategic direction of the firm, and how we will continue to build on our success. With that, let me turn the call over to Justin.
Thanks, Harvey. Good morning, everyone. I'd just like to start by saying how excited I am to assume the CFO role and have the opportunity to work more with each of you. And of course, a big thank you to John Redett for his time and leadership as CFO and for his help and guidance, which has made this transition so seamless. Turning to our results, in 2025, we had our third best year ever in terms of distributable earnings. We generated $1.7 billion in DE for the year for $4.02 per share. This was up 11% from the prior year and is our highest level since 2022. For the fourth quarter, we generated $436 million of DE for $1.01 per share. Fee-related earnings were a record, $1.24 billion in 2025, a 12% organic growth rate, driven by sustained operating momentum across the firm.
The full-year results significantly exceeded our initial guidance, and for the fourth quarter, FRE was $290 million. Total fee revenues were a record, $2.6 billion for the full year, a 10% organic growth rate. Fee revenues were primarily driven by Carlyle AlpInvest, which was up 46%, and Global Credit, which was up 13%. For the quarter, fee revenues were $670 million, an increase of 2% year-over-year. Our full-year FRE margin was also a record, 47%, up from 46% last year. This margin expansion reflects continued operating discipline and the scalability of our model. Three years ago, we outlined an organic growth strategy, which has clearly been successful as we have delivered consistent earnings growth. We continue to invest in priority growth initiatives such as global wealth, insurance solutions, and asset-backed finance, among others, and see significant opportunity in each for continued growth.
We remain focused on investing for growth and expect that margins will further expand as revenues continue to scale. In addition to record financial metrics, we had an incredible year of activity across the platform in 2025. Inflows totaled $54 billion, well above our initial guidance in our third-best year on record. Inflows increased 32% year-over-year, led by Global Credit and Carlyle AlpInvest, which each increased by more than 60%. Evergreen Wealth inflows were also a record in 2025, which more than doubled the prior record set in 2024. For the fourth quarter, we generated $9.2 billion of inflows across the firm, with more than 1/2 of that total from a diverse set of strategies in Global Credit.
Deployment was a record, $54 billion in 2025, up more than 25% versus last year, led by a more than 40% increase at Carlyle AlpInvest and nearly 30% growth in Global Private Equity. We deployed $17 billion in capital in the fourth quarter alone. With $88 billion of available capital across the firm, we are well positioned to continue deploying capital throughout our business. Realized proceeds totaled $34 billion, almost 20% higher year-over-year, and our second best year on record, reflecting improving exit conditions. We returned 17% of beginning value over the past year, significantly higher than the industry average. We realized $12 billion of proceeds in the fourth quarter alone for our fund investors. Turning now to segment performance, Carlyle AlpInvest generated a record $274 million of FRE for the year, up nearly 60% and almost 4x the level from just two years ago.
Growth was driven by strong institutional and global wealth fundraising and continued scale benefits across the platform. AlpInvest's distributable earnings were also a record $319 million in 2025, almost 70% higher than last year. The business remains well positioned for further growth as net accrued carry end of the year at $656 million, up 21% year-over-year. For the fourth quarter, AlpInvest's DE was $67 million, up 12% from the fourth quarter of 2024. In Global Credit, we delivered a record $402 million of FRE for 2025, up 21% from the prior year. FRE has grown at a 20% organic CAGR over the past three years. Net realized performance revenue tripled year-over-year, contributing to a record $481 million of DE in 2025. For the quarter, FRE increased 4% year-over-year to $102 million, and DE was up 7% to $123 million.
Global private equity realized over $18 billion of proceeds in 2025, the highest level in the past three years. In addition, we've already signed or closed $7 billion of proceeds in corporate private equity just year to date. Strong appreciation in our two most recent U.S. buyout funds drove net accrued performance revenue to nearly $2 billion. Finally, I'll say a few words on capital management and the balance sheet. We ended 2025 with a strong balance sheet, including $2 billion of cash, over $3 billion of investments, and almost $3 billion of net accrued carry. Our net accrued carry was up 9% sequentially in the fourth quarter, driven by strong appreciation in several of our largest funds. Together, these assets represent approximately $23 per share of pre-tax value. On capital management, we returned a record $1.2 billion of capital to shareholders between dividends and share buybacks during 2025.
Looking ahead, we entered 2026 with solid momentum across the platform. We expect continued growth supported by a diversified fundraising pipeline, expansion in global wealth, and improving capital markets conditions. While the macro environment remains complex, it is generally constructive for deployment and realization activity. We look forward to providing additional detail at our 2026 shareholder update on February 26th. With that, I'll now turn the call over to the operator to take your questions.